Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U7392AA | IM / LL |
mild swelling; pain at site of the injection; medication error/an inappropriate use due to administration of an expired product; This non-serious spontaneous safety report, with reference number 2025SA157135, was received by partner on 30-MAY-2025 and forwarded on 02-JUN-2025 from other heath professional. Due to the nature of the event, the causality between the events 'medication error/an inappropriate use due to administration of an expired product' and Vaxelis was not applicable. Further information is expected. Significant follow-up information was received by the partner on 27-JUN-2025 and forwarded on 27-JUN-2025, from HCP. The case is maintained as non-serious. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events, 'mild swelling' and 'pain at site of the injection'. Due to the nature of the event, the causality between the events 'medication error/an inappropriate use due to administration of an expired product' and Vaxelis was not applicable. Further information is not expected.
Prophylaxis
MMR; PREVENAR